IGM Biosciences Inc (NAS:IGMS)
$ 7.24 -0.07 (-0.96%) Market Cap: 427.33 Mil Enterprise Value: 174.49 Mil PE Ratio: 0 PB Ratio: 2.65 GF Score: 34/100

IGM Biosciences Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2022 / 05:40PM GMT
Release Date Price: $21.01 (-1.13%)
Michael Eric Ulz
Morgan Stanley, Research Division - Equity Analyst

All right. Good afternoon, everyone, and thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Mike Ulz, the biotech analyst here. And it's my pleasure to introduce Fred Schwarzer, CEO of IGM Biosciences. Format for today is a fireside chat. But just before we get started, I need to read a quick disclaimer. For important disclosures, please see the Morgan Stanley research website at www.morganstanley.com\researchdisclosures.

(Operator Instructions)

Questions & Answers

Michael Eric Ulz;Fred M. Schwarzer
Morgan Stanley, Research Division - Equity Analyst;IGM Biosciences, Inc. - CEO,

And with that, we can just hop straight into Q&A and maybe Thanks, Fred, for joining us here. And maybe if there's people who aren't familiar with IGM Biosciences, -- maybe you can just talk about some of the key differences between an IGM antibody and an IGG antibody and maybe why people have seemed to focus on IGG?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot